Last reviewed · How we verify

NCT04529668

Effect of Vitamin d Deficiency in Chronic Rhinosinusitis With Nasal Polyposis

Status unknown Phase 1 Last updated 31 August 2020
What this trial tests

Phase 1 trial testing vitamin D supplementation in Vitamin D Deficiency, Nasal Polyposis in 50 participants. Status unknown.

Timeline
1 October 2015
Primary endpoint
1 October 2020
20 October 2020

Quick facts

Lead sponsorAin Shams University
PhasePhase 1
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment50
Start date1 October 2015
Primary completion1 October 2020
Estimated completion20 October 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 60, any sex, with Vitamin D Deficiency, Nasal Polyposis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim of the work 1. To determine if chronic rhinosinusitis with nasal polyps' (CRSwNP) populations are vitamin D deficient. 2. To determine the possible anti-inflammatory effect of vitamin D supplementation (clinically \& histologically). \& investigate its relation to immunohistochemical tissue expression of basic fibroblast growth factor

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of vitamin D supplementation

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04529668.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing